USF Researchers Develop Living Heart Valves for Children

New valves designed to grow with patients could reduce the need for repeat surgeries in children with heart defects.

Updated on Oct. 16, 2026 in Heart Disease

A close-up of a medical heart valve prototype on a steel pedestal in a sterile, out-of-focus laboratory. — University of South Florida researchers are developing bio-integrative heart valves designed to grow with pediatric patients, potentially reducing future surgical interventions. AI Illustration. Upload story photo >

Live Poll

Should medical research prioritize developing permanent living replacements for chronic childhood heart defects?

University of South Florida researchers are developing living heart valves that integrate with a patient's body and cells. The innovation aims to solve the problem of current implants that do not grow as a child develops.

Why it matters

Current heart valves implanted in children require frequent follow-up surgeries as the patient ages. These living valves aim to grow alongside the child, potentially sparing young patients from multiple invasive procedures.

Congenital heart defects affect 40,000 babies born in the United States every year. The project is currently in early-stage pre-clinical testing to monitor how well the tissue-engineered valves integrate with cellular structures.

The players

University of South Florida

The university is a public research institution located in Tampa that oversees the development of this heart valve technology.

The details

The research focuses on creating heart valves that integrate with the patient's cells to facilitate tissue growth. By enabling the valve to grow with the child, medical teams hope to significantly reduce the frequency of follow-up surgeries.

October 15, 2026: The research progress was documented in a recent report.

Health Landscape

This development challenges the long-standing medical reliance on non-growing prosthetic heart valves that necessitate repeated surgeries in pediatric care. By moving toward living tissue integration, this research represents a potential shift in the evolution of pediatric cardiology.

This technology could eventually offer children with congenital defects a path to better long-term health with fewer invasive surgical interventions. Future stages of the research may expand the application of these growing valves to patients of all ages.

The takeaway

This research highlights the shift toward regenerative medicine in treating pediatric congenital heart conditions. Families should consult with their pediatric cardiologists to stay updated on how advancements in tissue-engineered implants may change treatment pathways.